{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:40:01Z","timestamp":1758987601563,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1053\/jinf.2001.0902","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:56:27Z","timestamp":1032429387000},"page":"246-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Toxic Epidermal Necrolysis Induced by Nevirapine Therapy: Description of Two Cases and Review of the Literature"],"prefix":"10.1016","volume":"43","author":[{"given":"A.M.","family":"Cattelan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Trevenzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sasset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sgarabotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lanzafame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Meneghetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/jinf.2001.0902_RF1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0190-9622(91)70176-3","article-title":"Toxic epidermal necrolysis: a review","volume":"25","author":"Avakian","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/jinf.2001.0902_RF2","first-page":"123","article-title":"Toxic epidermal necrolysis","volume":"59","author":"Schwartz","year":"1997","journal-title":"Cutis"},{"key":"10.1053\/jinf.2001.0902_RF3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1517\/13543784.5.9.1183","article-title":"Nevirapine: a review of its development, pharmacological profile and potential for clinical use","volume":"5","author":"Murphy","year":"1996","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1053\/jinf.2001.0902_RF4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/infdis\/171.3.537","article-title":"High dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection","volume":"171","author":"Havlir","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1053\/jinf.2001.0902_RF5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00042560-199502000-00005","article-title":"Phase I\/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus","volume":"8","author":"Cheeseman","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/jinf.2001.0902_RF6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.7326\/0003-4819-124-12-199606150-00001","article-title":"Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection","volume":"124","author":"D'Aquila","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/jinf.2001.0902_RF7","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1086\/515317","article-title":"A pilot study of nevirapine, indinavir, and lamivudine among patients with advanced human immunodeficiency virus disease who have had failure of combination nucleoside therapy","volume":"177","author":"Harris","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1053\/jinf.2001.0902_RF8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00002030-199606000-00009","article-title":"A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients","volume":"10","author":"Carr","year":"1996","journal-title":"AIDS"},{"key":"10.1053\/jinf.2001.0902_RF9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-4757-9209-6_27","article-title":"Current clinical experience with nevirapine for HIV infection","volume":"395","author":"Carr","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"10.1053\/jinf.2001.0902_RF10","first-page":"1115","article-title":"Nevirapine-induced hepatitis treated with corticosteroids?","volume":"12","author":"Leitze","year":"1988","journal-title":"AIDS"},{"key":"10.1053\/jinf.2001.0902_RF11","unstructured":"Jarrousse, B, Cohen, P, Berlureau, P, Bentata, M, Mahr, A, Guillevin, L, Nevirapine-induced fulminant hepatitis: presentation of case and analysis of risk factors, Seventh European Conference on Clinical aspects and treatment of HIV infection. Lisbon, October 1999"},{"key":"10.1053\/jinf.2001.0902_RF12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/520242","article-title":"Severe hepatic failure related to nevirapine treatment","volume":"29","author":"Cattelan","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jinf.2001.0902_RF13","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1001\/jama.284.21.2722","article-title":"Adverse effects associated with the use of nevirapine in HIV postexposure prophylaxis for 2 healthcare workers","volume":"284","author":"Johnson","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/jinf.2001.0902_RF14","first-page":"S12","volume":"14","year":"2000","journal-title":"AIDS"},{"key":"10.1053\/jinf.2001.0902_RF15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00002030-200107060-00007","article-title":"Hepatotoxicity in HIV-1 infected patients receiving nevirapine-containing antiretroviral therapy","volume":"15","author":"Martinez","year":"2001","journal-title":"AIDS"},{"key":"10.1053\/jinf.2001.0902_RF16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jama.279.12.930","article-title":"A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients The INCAS Trial","volume":"279","author":"Montaner","year":"1998","journal-title":"JAMA"},{"key":"10.1053\/jinf.2001.0902_RF17","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1097\/00002030-200011100-00010","article-title":"Comparison of twice-daily stavudine plus once-or twice-daily didanosine and nevirapine in early stages of HIV infection: the SCAN Study Group","volume":"14","author":"Garcia","year":"2000","journal-title":"AIDS"},{"key":"10.1053\/jinf.2001.0902_RF18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/317536","article-title":"Sex differences in nevirapine rash","volume":"32","author":"Bersoff-Matcha","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/jinf.2001.0902_RF19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(98)24008-6","article-title":"Nevirapine-associated Stevens-Johnson syndrome","volume":"351","author":"Warren","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/jinf.2001.0902_RF20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erytema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1053\/jinf.2001.0902_RF21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1365-2133.1999.02850.x","article-title":"Nevirapine-induced overlap Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"140","author":"Wetterwald","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1053\/jinf.2001.0902_RF22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00004630-199711000-00009","article-title":"Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage","volume":"18","author":"Engelhardt","year":"1997","journal-title":"J Burn Care Rehabil"},{"key":"10.1053\/jinf.2001.0902_RF23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.me.40.020189.001033","article-title":"Burn unit treatment of acute, severe exfoliating disorders","volume":"40","author":"Halebian","year":"1989","journal-title":"Ann Rev Med"},{"key":"10.1053\/jinf.2001.0902_RF24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1053\/jinf.2001.0902_RF25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-4362.1997.00192.x","article-title":"Plasmapheresis in toxic epidermal necrolysis","volume":"36","author":"Chaidemenos","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1053\/jinf.2001.0902_RF26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2230.1997.tb01044.x","article-title":"Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor","volume":"22","author":"Jarret","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"10.1053\/jinf.2001.0902_RF27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archderm.136.3.323","article-title":"Toxic epidermal necrolysis and Steven-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?","volume":"136","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445301909028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445301909028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:21:59Z","timestamp":1758986519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445301909028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0163445301909028"],"URL":"https:\/\/doi.org\/10.1053\/jinf.2001.0902","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2001,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxic Epidermal Necrolysis Induced by Nevirapine Therapy: Description of Two Cases and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/jinf.2001.0902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}